Quanterix (NASDAQ:QTRX) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.42) by 9.52 percent. This is a 11.63 percent increase over losses of $(0.43) per share from the same period last year. The company reported quarterly sales of $26.65 million which beat the analyst consensus estimate of $24.03 million by 10.89 percent. This is a 3.77 percent decrease over sales of $27.69 million the same period last year.
Credit Suisse Initiates Coverage On Fulgent Genetics with Outperform Rating, Announces Price Target of $65
Credit Suisse analyst Dan Leonard initiates coverage on Fulgent Genetics (NASDAQ:FLGT) with a Outperform rating and announces Price Target of $65.
